These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days. Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC Contraception; 2011 Jan; 83(1):62-7. PubMed ID: 21134505 [TBL] [Abstract][Full Text] [Related]
27. Medical termination of pregnancy. Christin-Maitre S; Bouchard P; Spitz IM N Engl J Med; 2000 Mar; 342(13):946-56. PubMed ID: 10738054 [TBL] [Abstract][Full Text] [Related]
28. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. Henshaw RC; Naji SA; Russell IT; Templeton AA BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094 [TBL] [Abstract][Full Text] [Related]
29. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review. Chen MJ; Creinin MD Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251 [TBL] [Abstract][Full Text] [Related]
30. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068 [TBL] [Abstract][Full Text] [Related]
33. Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia. Louie KS; Chong E; Tsereteli T; Avagyan G; Abrahamyan R; Winikoff B Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):76-80. PubMed ID: 27871191 [TBL] [Abstract][Full Text] [Related]
34. Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis. Di Carlo C; Savoia F; Morra I; Ferrara C; Sglavo G; Nappi C Gynecol Endocrinol; 2014 Aug; 30(8):605-7. PubMed ID: 24905726 [TBL] [Abstract][Full Text] [Related]
35. Early medical abortion: a new regimen up to 49 days' gestation. Ashima T; Vinita A; Shalini R Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315 [TBL] [Abstract][Full Text] [Related]
36. A review of developments in medical termination of pregnancy. Lipp A J Clin Nurs; 2008 Jun; 17(11):1411-8. PubMed ID: 18482139 [TBL] [Abstract][Full Text] [Related]
37. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial. Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099 [TBL] [Abstract][Full Text] [Related]
38. Medical and surgical options for induced abortion in first trimester. Hamoda H; Templeton A Best Pract Res Clin Obstet Gynaecol; 2010 Aug; 24(4):503-16. PubMed ID: 20418168 [TBL] [Abstract][Full Text] [Related]
39. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist. Maria B; Stampf F; Goepp A; Ulmann A Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966 [TBL] [Abstract][Full Text] [Related]
40. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol. Reeves MF; Monmaney JA; Creinin MD Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]